• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三支血管病变患者中[具体基因名称1]和[具体基因名称2]基因多态性与主要心脑血管事件的关联

Association of and Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease.

作者信息

Zhao Xueyan, Li Jiawen, Tang Xiaofang, Liu Ru, Xu Jingjing, Xu Lianjun, Jiang Lin, Huang Keyong, Tian Jian, Feng Xinxing, Wu Yajie, Zhang Yin, Wang Dong, Sun Kai, Xu Bo, Zhao Wei, Hui Rutai, Gao Runlin, Song Lei, Yuan Jinqing

机构信息

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Hum Gene Ther. 2021 Jun;32(11-12):581-588. doi: 10.1089/hum.2020.229. Epub 2021 Jan 22.

DOI:10.1089/hum.2020.229
PMID:33167740
Abstract

Three-vessel disease (TVD) is a severe coronary heart disease (CHD) with poor prognosis. Niemann-Pick C1-like 1 () is a transporter protein for exogenous cholesterol absorption, and 3-hydroxy-3-methylglutaryl-coenzyme A reductase () is a rate-limiting enzyme for cholesterol synthesis. We aimed to investigate the association between and gene polymorphisms and major adverse cardiac and cerebrovascular events (MACCE) in patients with TVD. A total of 342 TVD patients were consecutively enrolled and followed up for 1-year MACCE (a composite of all-cause death, myocardial infarction, revascularization, readmission, and stroke) as TVD event group, and 344 patients without CHD were control group. Four single-nucleotide polymorphisms (SNPs), rs11763759, rs4720470, rs2072183, and rs2073547, on gene and four SNPs, rs12916, rs2303151, rs2303152, and rs4629571, on gene were genotyped. Multivariate logistic regression analysis showed that rs4720470 of was associated with higher risk of TVD with MACCE in codominant model (odds ratio [OR]: 1.315; 95% confidence intervals [CI]: 1.007-1.716,  = 0.044), and that rs2303151 of was associated with higher in recessive (OR: 3.383; 95% CI: 1.040-10.998,  = 0.043) and codominant (OR: 1.458; 95% CI: 1.038-2.047,  = 0.030) model, respectively. Patients with both variant rs4720470 in codominant model and variant rs2303151 in recessive model related to a higher risk (OR: 6.772, CI: 1.338-34.280;  = 0.021). We reported for the first time that the rs4720470 on gene and rs2303151 on gene were associated with risk of 1-year MACCE in TVD.

摘要

三支血管病变(TVD)是一种预后较差的严重冠心病(CHD)。尼曼-匹克C1样1蛋白(NPC1L1)是外源性胆固醇吸收的转运蛋白,3-羟基-3-甲基戊二酰辅酶A还原酶(HMGCR)是胆固醇合成的限速酶。我们旨在研究NPC1L1和HMGCR基因多态性与TVD患者主要不良心脑血管事件(MACCE)之间的关联。连续纳入342例TVD患者作为TVD事件组,随访1年的MACCE(全因死亡、心肌梗死、血运重建、再入院和中风的综合指标),344例无CHD患者作为对照组。对NPC1L1基因上的4个单核苷酸多态性(SNP),即rs11763759、rs4720470、rs2072183和rs2073547,以及HMGCR基因上的4个SNP,即rs12916、rs2303151、rs2303152和rs4629571进行基因分型。多因素逻辑回归分析显示,NPC1L1基因的rs4720470在共显性模型中与TVD合并MACCE的较高风险相关(比值比[OR]:1.315;95%置信区间[CI]:1.007-1.716,P = 0.044),HMGCR基因的rs2303151在隐性模型(OR:3.383;95% CI:1.040-10.998,P = 0.043)和共显性模型(OR:1.458;95% CI:1.038-2.047,P = 0.030)中分别与较高风险相关。共显性模型中携带rs4720470变异和隐性模型中携带rs2303151变异的患者相关风险更高(OR:6.772,CI:1.338-34.280;P = 0.021)。我们首次报道NPC1L1基因上的rs4720470和HMGCR基因上的rs2303151与TVD患者1年MACCE风险相关。

相似文献

1
Association of and Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease.三支血管病变患者中[具体基因名称1]和[具体基因名称2]基因多态性与主要心脑血管事件的关联
Hum Gene Ther. 2021 Jun;32(11-12):581-588. doi: 10.1089/hum.2020.229. Epub 2021 Jan 22.
2
Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease.NPC1L1 和 HMGCR 基因多态性与早发三血管病变患者冠状动脉钙化的关系。
BMC Med Genomics. 2024 Jan 17;17(1):22. doi: 10.1186/s12920-024-01802-0.
3
Novel polymorphism of the HMGCR gene related to the risk of diabetes in premature triple-vessel disease patients.与早发三血管病变患者糖尿病风险相关的 HMGCR 基因新型多态性。
J Gene Med. 2022 Sep;24(9):e3445. doi: 10.1002/jgm.3445. Epub 2022 Sep 4.
4
Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease.NPC1L1和HMGCR基因变异与早发三支血管冠状动脉疾病的关系
Front Cardiovasc Med. 2021 Dec 1;8:704501. doi: 10.3389/fcvm.2021.704501. eCollection 2021.
5
HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins.载脂蛋白基因多态性与中强度他汀治疗的早发三血管病变患者的残余胆固醇风险相关。
BMC Cardiovasc Disord. 2023 Jun 24;23(1):317. doi: 10.1186/s12872-023-03285-w.
6
Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.自然随机分配降低低密度脂蛋白胆固醇对由NPC1L1、HMGCR或两者的多态性介导的冠心病风险的影响:一项2×2析因孟德尔随机化研究。
J Am Coll Cardiol. 2015 Apr 21;65(15):1552-61. doi: 10.1016/j.jacc.2015.02.020. Epub 2015 Mar 11.
7
Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.载脂蛋白基因附近的 HMG-CoA 还原酶、NPC1L1 和 PCSK9 抑制物与乳腺癌和前列腺癌的相关性。
Breast Cancer Res. 2022 Feb 12;24(1):12. doi: 10.1186/s13058-022-01508-0.
8
Susceptible gene polymorphism in patients with three-vessel coronary artery disease.三血管病变患者易感基因多态性。
BMC Cardiovasc Disord. 2020 Apr 15;20(1):172. doi: 10.1186/s12872-020-01449-6.
9
The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.年龄和性别对冠心病患者 HMGCR 启动子-911 SNP(rs33761740)与血清脂质关系的影响。
Gene. 2013 Oct 10;528(2):93-8. doi: 10.1016/j.gene.2013.07.056. Epub 2013 Aug 8.
10
Chlorogenic acid regulates the expression of NPC1L1 and HMGCR through PXR and SREBP2 signaling pathways and their interactions with HSP90 to maintain cholesterol homeostasis.绿原酸通过 PXR 和 SREBP2 信号通路及其与 HSP90 的相互作用来调节 NPC1L1 和 HMGCR 的表达,以维持胆固醇的体内平衡。
Phytomedicine. 2024 Jan;123:155271. doi: 10.1016/j.phymed.2023.155271. Epub 2023 Dec 9.

引用本文的文献

1
Associations Between Gene Variants of Lipid-Lowering Drug Targets and Adverse Outcomes After Ischemic Stroke.降脂药物靶点基因变异与缺血性脑卒中不良结局的相关性。
J Am Heart Assoc. 2024 Nov 19;13(22):e036544. doi: 10.1161/JAHA.124.036544. Epub 2024 Nov 15.
2
Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease.NPC1L1 和 HMGCR 基因多态性与早发三血管病变患者冠状动脉钙化的关系。
BMC Med Genomics. 2024 Jan 17;17(1):22. doi: 10.1186/s12920-024-01802-0.
3
HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins.
载脂蛋白基因多态性与中强度他汀治疗的早发三血管病变患者的残余胆固醇风险相关。
BMC Cardiovasc Disord. 2023 Jun 24;23(1):317. doi: 10.1186/s12872-023-03285-w.
4
Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease.NPC1L1和HMGCR基因变异与早发三支血管冠状动脉疾病的关系
Front Cardiovasc Med. 2021 Dec 1;8:704501. doi: 10.3389/fcvm.2021.704501. eCollection 2021.